Sign In
Buy AXGN
$40.63
+1.17 (+2.97%)
At Close: Jun 03, 2026
Axogen, Inc. to Report First Quarter 2024 Financial Results and Host Conference Call on May 2, 2024
07:00am, Tuesday, 16'th Apr 2024
ALACHUA, Fla. and TAMPA, Fla., April 16, 2024 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries,
AxoGen, Inc. (AXGN) Q4 2023 Earnings Call Transcript
11:03am, Tuesday, 05'th Mar 2024
AxoGen, Inc. (NASDAQ:AXGN ) Q4 2023 Earnings Call Transcript March 5, 2024 8:00 AM ET Company Participants Harold Tamayo - VP, Finance and IR Karen Zaderej - Chairman, CEO and President Nir Naor - CFO
Axogen, Inc Reports 2023 Fourth Quarter and Full-Year Financial Results
07:00am, Tuesday, 05'th Mar 2024
ALACHUA, Fla. and TAMPA, Fla., March 05, 2024 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries,
4 Must-Buy Stocks for Remarkable Earnings Acceleration
08:06am, Monday, 04'th Mar 2024
Some of the notable companies to have witnessed solid earnings acceleration as of now are Protagonist Therapeutics (PTGX), AxoGen (AXGN), Western Digital (WDC) and Phunware (PHUN).
AxoGen (AXGN) Is a Great Choice for 'Trend' Investors, Here's Why
09:51am, Wednesday, 28'th Feb 2024
AxoGen (AXGN) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "
AxoGen, Inc. (AXGN) Hit a 52 Week High, Can the Run Continue?
10:16am, Monday, 26'th Feb 2024
AxoGen (AXGN) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
3 Best Stocks to Buy for Remarkable Earnings Acceleration
07:11am, Friday, 16'th Feb 2024
Invest in stocks such as AxoGen (AXGN), Western Digital (WDC) and Gen Digital (GEN) as of now for superb earnings acceleration.
Axogen, Inc. to Report 2023 Fourth Quarter and Full-Year Financial Results on March 5, 2024
04:30pm, Tuesday, 13'th Feb 2024
ALACHUA, Fla. and TAMPA, Fla., Feb. 13, 2024 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, t
Here's Why Momentum in AxoGen (AXGN) Should Keep going
09:51am, Monday, 12'th Feb 2024
If you are looking for stocks that are well positioned to maintain their recent uptrend, AxoGen (AXGN) could be a great choice. It is one of the several stocks that passed through our "Recent Price St
Is AxoGen (AXGN) Stock Outpacing Its Medical Peers This Year?
10:42am, Tuesday, 06'th Feb 2024
Here is how AxoGen (AXGN) and Boston Scientific (BSX) have performed compared to their sector so far this year.
Company Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
04:15pm, Friday, 02'nd Feb 2024
ALACHUA, Fla. and TAMPA, Fla., Feb. 02, 2024 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, t
4 Top Stocks That Flaunt Solid Earnings Acceleration
07:31am, Monday, 29'th Jan 2024
Invest in stocks such as AxoGen (AXGN), Western Digital (WDC), Accolade (ACCD) and Credo Technology (CRDO) for superb earnings acceleration.
Axogen, Inc. Announces Positive Topline Results from REPOSE, a Prospective, Randomized Clinical Trial of Axoguard Nerve Cap
05:00pm, Thursday, 18'th Jan 2024
REPOSE® met its primary endpoint of non-inferiority between the pain visual analog scale outcomes for neurectomy with Axoguard Nerve Cap® vs. standard-of-care neurectomy at Month 12.
3 Stocks Worth a Look for Solid Earnings Acceleration
07:31am, Thursday, 11'th Jan 2024
Keep a tab on stocks such as Aspen Aerogels (ASPN), AxoGen (AXGN) and Credo Technology Group (CRDO) for superb earnings acceleration.
Axogen Reports Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2023
04:45pm, Thursday, 04'th Jan 2024
ALACHUA, Fla. and TAMPA, Fla., Jan. 04, 2024 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, t
